Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA).
British Journal of Cancer.
Times cited: 11
The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographicaly diverse populations.
Protein and Cell.
Times cited: 72